Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures

Male 0301 basic medicine MESH: Hippocampus [SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology Blotting, Western MESH: Neurons Receptors, Nicotinic MESH: Mice, Knockout Hippocampus MESH: Neurochemistry MESH: Animals, Newborn Antibodies Mice 03 medical and health sciences MESH: Mice, Inbred C57BL Antibody Specificity MESH: Bungarotoxins MESH: Synaptic Transmission MESH: Blotting, Western Animals MESH: Animals Electrophoresis, Gel, Two-Dimensional MESH: Antibody Specificity MESH: Mice Cerebral Cortex Mice, Knockout Neurons MESH: Acetylcholine MESH: Antibodies MESH: Immunohistochemistry Neurochemistry MESH: Electrophoresis, Gel, Two-Dimensional MESH: Protein Subunits Bungarotoxins Immunohistochemistry MESH: Cerebral Cortex MESH: Male Acetylcholine 3. Good health Mice, Inbred C57BL Protein Subunits Animals, Newborn MESH: Receptors, Nicotinic Female MESH: Female
DOI: 10.1111/j.1471-4159.2007.04498.x Publication Date: 2007-04-10T09:45:36Z
ABSTRACT
AbstractNicotinic acetylcholine receptors play important roles in numerous cognitive processes as well as in several debilitating central nervous system (CNS) disorders. In order to fully elucidate the diverse roles of nicotinic acetylcholine receptors in CNS function and dysfunction, a detailed knowledge of their cellular and subcellular localizations is essential. To date, methods to precisely localize nicotinic acetylcholine receptors in the CNS have predominantly relied on the use of anti‐receptor subunit antibodies. Although data obtained by immunohistology and immunoblotting are generally in accordance with ligand binding studies, some discrepancies remain, in particular with electrophysiological findings. In this context, nicotinic acetylcholine receptor subunit‐deficient mice should be ideal tools for testing the specificity of subunit‐directed antibodies. Here, we used standard protocols for immunohistochemistry and western blotting to examine the antibodies raised against the α3‐, α4‐, α7‐, β2‐, and β4‐nicotinic acetylcholine receptor subunits on brain tissues of the respective knock‐out mice. Unexpectedly, for each of the antibodies tested, immunoreactivity was the same in wild‐type and knock‐out mice. These data imply that, under commonly used conditions, these antibodies are not suited for immunolocalization. Thus, particular caution should be exerted with regards to the experimental approach used to visualize nicotinic acetylcholine receptors in the brain.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (57)
CITATIONS (172)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....